Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Symphonix Devices Vibrant "soundbridge" hearing device slated to enter clinicals in July.

This article was originally published in The Gray Sheet

Executive Summary

SYMPHONIX DEVICES VIBRANT "SOUNDBRIDGE" CLINICAL TRIALS are scheduled to begin this summer in the U.S. and Europe, the company says. San Jose, California-based Symphonix received an investigational device exemption in January for the semi-implantable microphone-amplifier-transducer system, which is designed to aid patients with moderate-to-severe hearing loss who "fall between satisfied hearing aid users and candidates for a cochlear implant, who cannot be helped at all by amplification."
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT006057

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel